Atlas Trials

Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD

Clinical trial NCT01754259 · COMPLETED

Trial details

NCT number
NCT01754259
Sponsor
Brigham and Women's Hospital
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes, Type IDiabetes, Type IIAnginaCoronary Artery Disease
Start date
2013-04-01
Primary completion
2015-10-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.